Insight

$Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma$

medicalnewstoday.com

Jun 23, 2024, 19:16

Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute, shared on X/Twitter:

“Honored to by co-lead author with Naresh Bumma on this amazing paper: Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma | Journal of Clinical Oncology.”

$Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma 1$

Visit the article site.
Source: Joshua Richter/X

Anasuya Hazra Anita Boyapati Attaya Suvannasankha cancer Chang-Ki Min Dhruti Chokshi George D. Yancopoulos Glenn S. Kroog Hans C. Lee Hematology Ja Min Byun James E. Hoffman Jeffrey A. Zonder Jing Christine Ye Joaquín Martínez-Lopez Joseph J. Maly Joshua Richter Journal of Clinical Oncology Ka Lung Wu Kaniel Cassady Karen Rodriguez Lorenc L. Andres Sirulnik Linvoseltamab Madhav V. Dhodapkar Mansi R. Shah Marie-Christiane Vekemans Markus Munder Matthew J. Pianko Michelle DeVeaux Naresh Bumma OncoDaily Oncology Rachid Baz Rebecca Silbermann relapsed/refractory multiple myeloma Sundar Jagannath Suzanne Lentzsch Swathi Namburi Yariv Houvras

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage